Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)
NCT04618081
·
clinicaltrials.gov ↗
COMPLETED
Status
151
Enrollment
INDUSTRY
Sponsor class
Conditions
Lymphoma Nonhodgkin
Sponsor
Celgene